FDA DEVICE FACTS
Magnes-C Anterior Cervical Plate System
Fellowship of Orthopaedic Researchers, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Magnes-C™ Anterior Cervical Plate System is intended for anterior screw fixation of the cervical spine (C2 to T1). The system is to be used as an adjunct to fusion for the treatment of the following indications: degenerative disc disease (defined as neck pain of discogenic origin with the degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, trauma (i.e., fractures or dislocations), spinal stenosis, deformity (i.e., kyphosis, lordosis or scoliosis), tumors, pseudarthrosis or failed previous fusion. Materials: The patient contacting portion of the Magnes-C™ Anterior Cervical Plate System implants are manufactured from titanium alloy as described by ASTM F136. All instruments are manufactured from medical grade stainless steels according to ASTM F899, some of which have silicone or Radel handles. Primary Predicate: Zavation Cervical Plate System (Zavation LLC – K130030) Additional Predicates: Cervical Spine Locking Plate (CSLP) (Synthes Spine – K945700), Biomet MaxAn® Anterior Cervical Plate System (Biomet Spine LLC – K133518)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。